BENGALURU, Aug 19 (Reuters) – India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter said could be worth up to 50 billion rupees ($671.89 million).

Emcure is the latest Indian company to tap capital markets this year in a fund-raising frenzy driven by abundant liquidity and record-high stock markets.

Read more at https://www.reuters.com/world/india/bain-backed-emcure-pharma-expec...